Targeted drug combo shows promise against melanoma
CHICAGO (Reuters) - The combination of two experimental pills developed by GlaxoSmithKline Plc has shown promise as a treatment for melanoma, the most deadly type of skin cancer, according to new research.
No comments:
Post a Comment